Business Standard

Aspira Pathlab & Diagnostics standalone net profit declines 89.47% in the September 2021 quarter

Image

Capital Market

Sales decline 35.13% to Rs 3.49 crore

Net profit of Aspira Pathlab & Diagnostics declined 89.47% to Rs 0.14 crore in the quarter ended September 2021 as against Rs 1.33 crore during the previous quarter ended September 2020. Sales declined 35.13% to Rs 3.49 crore in the quarter ended September 2021 as against Rs 5.38 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales3.495.38 -35 OPM %16.3334.57 -PBDT0.521.68 -69 PBT0.141.33 -89 NP0.141.33 -89

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 15 2021 | 2:02 PM IST

Explore News